Vesper Medical
Wayne, US · Founded 2016 · Delaware corporation · 5 known investors
Find your way into Vesper Medical
27 people in our graph share verified history with the Vesper Medical team — schools, employers, funds. One of them is your warm intro.
Charlie Falconeunlockedknows Monica Klos · together at Villanova University (overlapped)
×11knows the team · via Villanova University
Vesper Medical develops a modular venous stent portfolio designed to address the anatomical challenges of the iliac and femoral veins for treating deep venous disease. The devices are intended for physicians treating patients with deep venous disease, positioning the company in the vascular medical device space.
Founders & leadership
BJ
Bruce J. ShookPresident and CEO
MK
Monica KlosinController & Treasurer2016–2022Monica Klos brings more than 30 years of accounting and finance experience, including work at Big Four firms and roles in both public and private companies. At Vesper Medical, she oversees corporate accounting, financial reporting, budgeting, and risk management.
NH
PS
Peter SchneiderNamed on SEC filing
MG
Mark GarciaNamed on SEC filing
DW
Dennis W. WahrNamed on SEC filing
Board
PS
P. Sherrill NeffBoard director
JK
Investors · 5
Reported raises · per SEC filings
Form D private placements$22.5M disclosed across 2 rounds · 2016–2019
▶$7MraisedJun 2019 · 30 investors · Other Health CareRule 506(b)
▶$7MraisedJun 2019 · 30 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bruce J. ShookExecutive Officer, Director
- Mark GarciaDirector
- Neil HattangadiDirector
- P. Sherill NeffDirector
- Peter SchneiderDirector
- Marc PennaExecutive Officer
- Josh MakowerDirector
- Monica KlosExecutive Officer
- Joseph C. Griffin, IIIExecutive Officer
- Michael LongoExecutive Officer
- Howard RosenExecutive Officer
- Dennis W. WahrDirector
- Offering amount
- $37.2M
- Amount sold
- $7M
- Proceeds to insiders
- $9M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$15.5MraisedMay 2018 · 37 investors · Other Health CareRule 506(b)
▶$15.5MraisedMay 2018 · 37 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- P. Sherrill NeffDirector
- Neil HattangadiDirector
- Peter SchneiderDirector
- Mark GarciaDirector
- Justin KleinDirector
- Bruce J. ShookExecutive Officer, Director
- Monica KlosExecutive Officer
- Dennis W. WahrDirector
- Offering amount
- $15.5M
- Amount sold
- $15.5M
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Verse Medical7 shared keywordsVerse Medical builds software to coordinate home-based healthcare services, replacing fragmented vendor interactions and outdated communication methods with a unified platform for in-home care providers.
Cqmedical6 shared keywordsCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.
Boston Scientific5 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Vantis Vascular5 shared keywordsVantis Vascular develops vascular intervention technology, including the CrossFast integrated vascular delivery system with an auto-locking inner monorail microcatheter and outer delivery catheter for complex PCI procedures. Founded by physicians, the company is also developing next-generation intravascular lithotripsy (IVL) and peripheral below-the-knee (BTK) solutions for vascular interventionalists.</parameter>
<parameter name="founders">[{"full_name": "Jason Turner", "title": "Chief Executive Officer"}, {"full_name": "Tim Fischell", "title": "Chief Medical Officer"}, {"full_name": "Frank Saltiel", "title": "Chief Clinical Officer"}, {"full_name": "Gary McCord", "title": "Chief Commercial Officer"}, {"full_name": "Mike Mirizzi", "title": "Chief Technology Officer"}, {"full_name": "Marc Monahan", "title": "Chief Financial Officer"}]</parameter>
<parameter name="hq_city">San Jose
Companies competing with Vesper Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Vesper Medical do?
- Vesper Medical develops a modular venous stent portfolio designed to address the anatomical challenges of the iliac and femoral veins for treating deep venous disease. The devices are intended for physicians treating patients with deep venous disease, positioning the company in the vascular medical device space.
- Who are Vesper Medical's investors?
- Vesper Medical's investors include New Enterprise Associates (NEA), Gilde Healthcare, Lightstone Ventures, Vensana Capital, 415 Capital.
- How much funding has Vesper Medical raised?
- Vesper Medical has disclosed $22.5M raised across 2 rounds.
- Where is Vesper Medical headquartered?
- Vesper Medical is headquartered in Wayne, US.